Bio Essence Corp

Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services. The business was reorganized over time through subsidiaries, with manufacturing and distribution previously housed in BEP and BEH, and a dormant prescription-medicine R&D subsidiary, McBE, later dissolved. Following the disposal of its manufacturing subsidiary, the company now relies mainly on outsourced OEM service activity and supplement sales rather than in-house production. Recent filings show a business in transition, with management emphasizing OEM services as the core revenue driver and a source of better gross margins.

47,4 %

75,3 %

47,2 %

+485,8 %

0.17

0.17

— Bio Essence Corp
%
OEM / manufacturing services85% Contract manufacturing and OEM services provided to customers that need outsourced production support.
Health supplement products10% Branded or distributed health supplement products sold directly or through customers.
Shipping and delivery income5% Ancillary logistics and delivery charges billed in connection with product shipments.

Bio Essence sells primarily to customers that source health supplements or outsource manufacturing work, rather than to...

  • OEM service customersprimary

    Buy outsourced manufacturing and production support, mainly to avoid building their own facilities and to scale orders quickly.

  • Health supplement product buyerssecondary

    Purchase finished supplement products for resale or distribution, typically where product sourcing and packaging matter.

  • Logistics and shipping customersemerging

    Pay for shipping and delivery income associated with product movement and fulfillment.

The company is incorporated in California and operates from the United States, with its functional currency reported as...

  • •United States is the core operating base and reporting currency is USD
  • •California is the main corporate and subsidiary footprint in the filings
  • •No country-level revenue disclosure was provided in the excerpts
  • •Outsourced OEM model reduces dependence on owned manufacturing locations
  • •Geographic exposure is mainly tied to customer demand and third-party suppliers

Management is trying to reposition the business around OEM service revenue, which the filings say carries a higher...

01
Grow OEM service revenueshort-term

OEM services are now the main revenue engine and appear to generate better gross margins than product sales.

02
Expand sales and marketing executionshort-term

Management believes stronger selling efforts and promotions are needed to rebuild revenue and customer acquisition.

03
Secure additional financingshort-term

The company has substantial accumulated deficits and disclosed going-concern uncertainty, so liquidity support is essential.

The most immediate company-specific risk is going-concern uncertainty, driven by recurring losses and a large...

critical

Going-concern uncertainty

The company disclosed substantial doubt about its ability to continue as a going concern due to losses and accumulated deficit.

Scope
Liquidity and business continuity
Materiality
high
high

Customer concentration in OEM services

Recent revenue growth was driven by a major order from a new customer, which can create dependence on a small number of accounts.

Scope
Revenue stability
Materiality
high
high

Outsourced manufacturing dependency

After disposing of BEP, the company no longer controls its own manufacturing and must rely on third parties for OEM execution.

Scope
Cost, quality, and delivery performance
Materiality
high
high

Financing and dilution risk

Management expects to raise funds through private/public offerings or loans, which may be difficult or dilutive.

Scope
Capital structure and shareholder value
Materiality
high
ASC 606 revenue recognition
Quarterly revenue volatility
Revenue reserves for discounts, returns, and rebates
Net revenue and receivables
Accounts receivable allowance
Earnings and balance sheet valuation
Going-concern disclosure
Financial statement interpretation

BIOFORCE NANOSCIENCES HOLDINGS, INC.

BFNH · Laboratory Analytical Instruments

BIOREGENX, INC.

BRGX · Services-Computer Programming, Data Processing, Etc.

Bio Green Med Solution, Inc.

BGMS · Wholesale-Durable Goods, NEC

SOLESENCE, INC.

SLSN · Perfumes, Cosmetics & Other Toilet Preparations

Bespoke Extracts, Inc.

BSPK · Pharmaceutical Preparations

Green Planet Bio Engineering Co. Ltd.

GPLB · Biological Products, (No Diagnostic Substances)

: 11/08/2026